CDK4/6 Inhibitors in Melanoma: A Comprehensive Review

by Mattia Garutti, Giada Targato, Silvia Buriolla, Lorenza Palmero, Alessandro Marco Minisini, Fabio Puglisi
Published 2021-05-01

Find the Flame: Predictive Biomarkers for Immunotherapy in Melanoma

by Mattia Garutti, Serena Bonin, Silvia Buriolla, Elisa Bertoli, Maria Antonietta Pizzichetta, Iris Zalaudek, Fabio Puglisi
Published 2021-04-01

“To Anticipate”: Neoadjuvant Therapy in Melanoma with a Focus on Predictive Biomarkers

by Mattia Garutti, Silvia Buriolla, Elisa Bertoli, Maria Grazia Vitale, Ernesto Rossi, Giovanni Schinzari, Alessandro Marco Minisini, Fabio Puglisi
Published 2020-07-01

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer

by Lorenzo Gerratana, Lorenzo Gerratana, Debora Basile, Debora Basile, Alessandra Franzoni, Lorenzo Allegri, Davide Viotto, Carla Corvaja, Carla Corvaja, Lucia Bortot, Lucia Bortot, Elisa Bertoli, Elisa Bertoli, Silvia Buriolla, Silvia Buriolla, Giada Targato, Giada Targato, Lucia Da Ros, Stefania Russo, Marta Bonotto, Barbara Belletti, Gustavo Baldassarre, Giuseppe Damante, Fabio Puglisi, Fabio Puglisi
Published 2020-09-01

First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study

by Debora Basile, Lorenzo Gerratana, Carla Corvaja, Giacomo Pelizzari, Giorgia Franceschin, Elisa Bertoli, Lorenza Palmero, Diego Zara, Martina Alberti, Silvia Buriolla, Lucia Da Ros, Marta Bonotto, Mauro Mansutti, Simon Spazzapan, Marika Cinausero, Alessandro Marco Minisini, Gianpiero Fasola, Fabio Puglisi
Published 2021-06-01